课题基金 / 基金详情

VIOLENT BEHAVIOR, NEUROTRANSMITTERS, GLUCOSE METABOLISM, AND ALCOHOL ABUSE

VIOLENT BEHAVIOR, NEUROTRANSMITTERS, GLUCOSE METABOLISM, AND ALCOHOL ABUSE
暴力行为、神经递质、葡萄糖代谢和酒精滥用
批准号:
2565454
负责人:
M LINNOILA
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

M LINNOILA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have investigated neurotransmitter metabolites and glucose metabolism in incarcerated violent offenders, arsonists, and healthy volunteers. We have found that low cerebrospinal fluid (CSF), 5-hydroxyindoleacetic acid (5-HIAA) concentrations, and hypoglycemia during oral glucose tolerance tests are associated with each other and impulsive violent acts and fire setting. To elucidate the pathophysiology of the reactive hypoglycemia, englycemic insulin clamp studies with indirect calorimetry have been performed on more than 40 offenders and healthy volunteers. The data have not been analyzed, because initial power calculations indicated that a larger sample size is necessary. Sample collection for the molecular genetic family study on alcoholic violent offenders has been completed. The clinical data have been blind rated for psychiatric diagnoses and all biochemical and physiological data have been entered in the computers and double checked for errors. Molecular genetic analyses in the Laboratory of Neurogenetics are underway. Thirteen hundred DNA samples, which represent a random sample of Finns, and which are without identifiers, were received from Dr. Leena Peltoven in the National Public Health Institute in Helsinki. Together with our own control sample which consists of 300 volunteers, these samples will be used to establish the true allelic frequencies of rare polymorphisms among the Finnish population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VIOLENT BEHAVIOR, NEUROTRANSMITTERS, GLUCOSE METABOLISM, AND ALCOHOL ABUSE
CSF NEUROPEPTIDES AND PROSTAGLANDINS IN ALCOHOL WITHDRAWAL AND BRAIN DISEASE
VIOLENT BEHAVIOR, NEUROTRANSMITTERS, GLUCOSE METABOLISM, AND ALCOHOL ABUSE
CSF NEUROPEPTIDES AND PROSTAGLANDINS IN ALCOHOL WITHDRAWAL AND BRAIN DISEASE
海外基金